Regulation of the signal transduction program by drugs

Advances in Enzyme Regulation

Volumn 37, Issue , 1997, Pages 35-55

  Weber, George ^a   Shen, Fei ^a   Prajda, Noemi ^a,b   Yang, Hongyuan ^a   Li, Wei ^a   Yeh, Albert ^a   Csokay, Bela ^b   Olah, Edith ^b   Look, Katherine Y ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

1-PHOSPHATIDYLINOSITOL-4-PHOSPHATE 5-KINASE; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; GENISTEIN; INOSINATE DEHYDROGENASE; INOSITOL 1,4,5 TRISPHOSPHATE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLINOSITOL 4 PHOSPHATE KINASE; PHOSPHATIDYLINOSITOL KINASE; PHOSPHOLIPASE C; PHOSPHOTRANSFERASE; QUERCETIN; RIBAVIRIN; TIAZOFURIN;

ANIMAL; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL; CANCER CELL CULTURE; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME ANALYSIS; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; METABOLISM; NEOPLASM; NONHUMAN; ONCOGENE C MYC; ONCOGENE K RAS; RAT; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 4-KINASE; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DIFFERENTIATION; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; GENISTEIN; HUMANS; IMP DEHYDROGENASE; INOSITOL 1,4,5-TRISPHOSPHATE; NEOPLASMS; PHOSPHATIDYLINOSITOLS; PHOSPHOLIPASE C; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); QUERCETIN; RATS; RIBAVIRIN; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0030796278     PISSN: 00652571     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2571(96)00025-8     Document Type: Conference Paper

References (43)

1. 1. G. WEBER, Biochemical strategy of cancer cells and the design of chemotherapy: G. H. A. Clowes Memorial Lecture, Cancer Res. 43, 3466-3492 (1983).
2. 2. M.T. RIZZO and G. WEBER, 1-Phosphatidylinositol 4-kinase (EC 2.7.1.67): an enzyme linked with proliferation and malignancy, Cancer Res. 54, 2611-2614 (1994).
3. 3. R.L. SINGHAL, N. PRAJDA, Y.A. YEH and G. WEBER, 1-Phosphatidylinositol 4-phosphate 5-kinase (EC 2.7.1.68): a proliferation-and malignancy-linked signal transduction enzyme, Cancer Res. 54, 5574-5578 (1994).
4. 4. H. YANG, F. SHEN, Y. A. YEH, M. HERENYIOVA and G. WEBER, Phospholipase C (EC 3.1.4.11): a malignancy-linked signal transduction enzyme, Submitted (1997).
5. 5. R.L. SINGHAL, Y.A. YEH, K.Y. LOOK, G.W. SLEDGE Jr and G. WEBER, Coordinated increase in activities of the signal transduction enzymes PI kinase and PIP kinase in human cancer cells, Life Sci. 55, 1487-1492 (1994).
6. 6. R.L. SINGHAL, Y.A. YEH, N. PRAJDA, E. OLAH, G.W. SLEDGE Jr and G. WEBER, Quercetin down-regulates signal transduction in human breast carcinoma cells, Biochem. Biophys. Res. Commun. 208, 425-431 (1995).
7. 7. N. PRAJDA, R.L. SINGHAL, Y.A. YEH, E. OLAH, K.Y. LOOK and G. WEBER, Linkage of reduction in 1-phosphatidylinositol 4-kinase activity and inositol 1,4,5-trisphosphate concentration in human ovarian carcinoma cells treated with quercetin. Life Sci. 56, 1587-1593 (1995).
8. 8. G. WEBER, R.L. SINGHAL, N. PRAJDA, Y.A. YEH, K.Y. LOOK and G.W. SLEDGE Jr, Regulation of signal transduction, Advan. Enzyme Regul. 35, 1-21 (1995).
9. 9. K.Y. LOOK, G.P. SUTTON, Y. NATSUMEDA, J.N. EBLE, F.B. STEHMAN, C.E. EHRLICH, E. OLAH, N. PRAJDA, P. BOSZE, S. ECKHARDT and G. WEBER, Inhibition by tiazofurin of inosine 5′-phosphate dehydrogenase (IMP DH) activity in extracts of ovarian carcinomas, Gyn. Oncol. 47, 66-70 (1992).
10. 10. N. PRAJDA, Y. NATSUMEDA, T. IKEGAMI, M.A. REARDON, S. SZONDY, Y. HASHIMOTO, J. EMRANI and G. WEBER, Enzymic programs of rat bone marrow and the impact of acivicin and tiazofurin, Biochem. Pharmacol. 37, 875-880 (1988).
11. 11. G. WEBER, N. PRAJDA, H. YANG, Y.A. YEH, F. SHEN, R.L. SINGHAL, M. HERENYIOVA and K.Y. LOOK, Current issues in regulation of signal transduction, Advan. Enzyme Regul. 36, 33-55 (1996).
12. 12. G. WEBER, M. STUBBS and H.P. MORRIS, Metabolism of hepatomas of different growth rates in situ and during ischemia, Cancer Res. 31, 2177-2183 (1971).
13. 13. O.H. LOWRY, N.J. ROSEBROUGH, A.L. FARR and R.J. RANDALL, Protein measurement with the Folin phenol reagent, J. Biol. Chem. 193, 265-275 (1951).
14. 14. G. WEBER, F. SHEN, N. PRAJDA, Y.A. YEH, H. YANG, M. HERENYIOVA and K.Y. LOOK, Increased signal transduction activity and down-regulation in human cancer cells, Anticancer Res. 16, 3271-3282 (1996).
15. 15. R.C. JACKSON, G. WEBER and H.P. MORRIS, IMP dehydrogenase, an enzyme linked with proliferation and malignancy, Nature 256, 331-333 (1975).
16. 16. G. WEBER, N. PRAJDA, M. ABONYI, K.Y. LOOK and G. TRICOT, Tiazofurin: molecular and clinical action, Anticancer Res. 16, 3313-3322 (1996).
17. 17. Y. NATSUMEDA, S. OHNO, H. KAWASAKI, Y. KONNO, G. WEBER and K. SUZUKI, Two distinct cDNAs for human IMP dehydrogenase, J. Biol. Chem. 265, 5292-5295 (1990).
18. 18. Y. KONNO, Y. NATSUMEDA, M. NAGAI, Y. YAMAJI, S. OHNO, K. SUZUKI and G. WEBER, Expression of human IMP dehydrogenase types I and II in Escherichia coli and distribution in human normal and leukemic cell lines, J. Biol. Chem. 266, 508-509 (1991).
19. 19. M. NAGAI, Y. NATSUMEDA, Y. KONNO, R. HOFFMAN, S. IRINO and G. WEBER, Selective up-regulation of type II inosine 5′-monophosphate dehydrogenase messenger RNA expression in human leukemias, Cancer Res. 51, 3886-3890 (1991).
20. 20. G. WEBER, N. PRAJDA and R.C. JACKSON, Key enzymes of IMP metabolism: transformation-and progression-linked alterations in gene expression, Advan. Enzyme Regul. 14, 3-24 (1976).
21. 21. G. WEBER, Enzymology of cancer cells, part 1, New Engl. J. Med. 296, 486-493 (1977).
22. 22. G. WEBER, Enzymology of cancer cells, part 2, New Engl. J. Med. 296, 541-551 (1977).
23. 23. R.K. ROBINS, Nucleoside and nucleotide inhibitors of inosine monophosphate (IMP) dehydrogenase as potential antitumor inhibitors, Nucleosides & Nucleotides 1, 35-44 (1982).
24. 24. G.J. TRICOT, H.N. JAYARAM, E. LAPIS, Y. NATSUMEDA, Y. YAMADA, C.R. NICHOLS, P. KNEEBONE, N. HEEREMA, G. WEBER and R. HOFFMAN, Biochemically directed therapy of leukemia with tiazofurin, a selective blocker of inosine 5′-phosphate dehydrogenase activity, Cancer Res. 49, 3696-3701 (1989).
25. 25. G. TRICOT and G. WEBER, Biochemically targeted therapy of refractory leukemia and myeloid blast crisis of chronic granulocytic leukemia with tiazofurin, a selective blocker of inosine 5′-monophosphate dehydrogenase (IMPDH) activity, Anticancer Res. 16, 3341-3348 (1996).
26. 26. G. TRICOT, H.N. JAYARAM, G. WEBER and R. HOFFMAN, Tiazofurin: biological effects and clinical uses, Intl. J. Cell Cloning 8, 161-170 (1990).
27. 27. N. PRAJDA, Y. HATA, M. ABONYI, R.L. SINGHAL and G. WEBER, Sequential impact of tiazofurin and ribavirin on enzymic program of rat bone marrow, Cancer Res. 53, 5982-5986 (1993).
28. 28. D.G. WRIGHT, M.S. BOOSALIS, L.J. OSHRY and K. WARASKA, Tiazofurin effects on IMP dehydrogenase activity and expression in the leukemic cells of patients with CML in blast crisis, Anticancer Res. 16, 3349-3358 (1996).
29. 29. E. OLAH, Y. NATSUMEDA, T. IKEGAMI, Z. KOTE, M. HORANYI, J. SZELENYI, E. PAULIK, T. KREMMER, S.R. HOLLAN, J. SUGAR and G. WEBER, Induction of erythroid differentiation and modulation of gene expression by tiazofurin in K562 leukemia cells, Proc. Natl Acad. Sci. USA 85, 6533-6537 (1988).
30. 30. E. OLAH, Z. KOTE, Y. NATSUMEDA, Y. YAMAJI, G. JARAI, E. LAPIS, I. FINANCSEK and G. WEBER, Down-regulation of c-myc and c-Ha-ras gene expression by tiazofurin in rat hepatoma cells, Cancer Biochem. Biophys. 11, 107-117 (1990).
31. 31. G. WEBER, M. NAGAI, Y. NATSUMEDA, J.N. EBLE, H.N. JAYARAM, E. PAULIK, W. ZHEN, R. HOFFMAN and G. TRICOT, Tiazofurin down-regulates expression of c-Ki-ras oncogene in a leukemic patient, Cancer Commun. 3, 61-66 (1991).
32. 32. E. OLAH, B. CSOKAY, N. PRAJDA, Z. KOTE-JARAI, Y.A. YEH and G. WEBER, Molecular mechanisms in the antiproliferative action of taxol and tiazofurin, Anticancer Res. 16, 1-9 (1996).
33. 33. B. CSOKAY, N. PRAJDA, G. WEBER and E. OLAH, Molecular mechanisms in the antiproliferative action of quercetin, Life Sci., Accepted for publication (1997).
34. 34. M.S. LUI, M.A. FADERAN, J.J. LIEPNICKS, Y. NATSUMEDA, E. OLAH, H.N. JAYARAM and G. WEBER, Modulation of IMP dehydrogenase activity and guanylate metabolism by tiazofurin (2-β-D-ribofuranosylthiazole-4-carboxamide), J. Biol. Chem. 259, 5078-5082 (1984).
35. 35. Y. HATA, Y NATSUMEDA and G. WEBER, Tiazofurin decreases Ras-GTP complex in K562 cells, Oncol. Res. 5, 161-164 (1993).
36. 36. H. NISHIOKA, M. IMOTO, T. SAWA, M. HAMADA, H. NAGANAWA, T. TAKEUCHI and K. UMEZAWA, Screening of phosphatidylinositol kinase inhibitors from streptomyces, J. Antibiotics 42, 823-825 (1989).
37. 37. G. PETERSON, Evaluation of the biochemical targets of genistein in tumor cells, J. Nutr. 125, 784S-789S (1995).
38. 38. S. BARNES and T.G. PETERSON, Biochemical targets of the isoflavone genistein in tumor cell lines (43840), Proc. Soc. Exptl Biol. Med. 208, 103-108 (1995).
39. 39. A. CONSTANTINOU and E. HUBERMAN, Genistein as an inducer of tumor cell differentiation: possible mechanisms of action (43841), Proc. Soc. Exptl Biol. Med. 208, 109-115 (1995).
40. 40. M. MAKISHIMA, Y. HONMA, M. HOZUMI, K. SAMPI, M. HATTORI, K. UMEZAWA and K. MOYOYOSHI, Effects of inhibitors of protein tyrosine kinase activity and/or phosphatidylinositol turnover on differentiation of some human myelomonocytic leukemia cells, Leuk. Res. 15, 701-708 (1991).
41. 41. Y. OZAKI, Y. YATOMI, Y. JINNAI and S. KUME, Effects of genistein, a tyrosine kinase inhibitor, on platelet functions, Biochem. Pharmacol. 46, 395-403 (1993).
42. 2-M, Cancer Res. 53, 1328-1331 (1993).
43. 43. K. YANAGIHARA, A. ITO, T. TOGE and M. NUMOTO, Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract, Cancer Res. 53, 5815-5821 (1993).